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Stature, bone size, and bone mass are interrelated traits with high heritability, but the major genes that govern
these phenotypes remain unknown. Independent genomewide quantitative-trait locus studies have suggested a locus
for bone-mineral density and stature at chromosome 11q12-13, a region harboring the low-density lipoprotein
receptor–related protein 5 (LRP5) gene. Mutations in the LRP5 gene were recently implicated in osteoporosis-
pseudoglioma and “high-bone-mass” syndromes. To test whether polymorphisms in the LRP5 gene contribute to
bone-mass determination in the general population, we studied a cross-sectional cohort of 889 healthy whites of
both sexes. Signiﬁcant associations were found for a missense substitution in exon 9 (c.2047GrA) with lumbar
spine (LS)–bone-mineral content (BMC) ( ), with bone area ( ), and with stature ( ).Pp .0032 Pp .0014 Pp .0062
The associations were observed mainly in adult men, in whom LRP5 polymorphisms accounted for 15% of the
traits’ variances. Results of haplotype analysis of ﬁve single-nucleotide polymorphisms in the LRP5 region suggest
that additional genetic variation within the locus might also contribute to bone-mass and size determination. To
conﬁrm our results, we investigated whether LRP5 haplotypes were associated with 1-year gain in vertebral bone
mass and size in 386 prepubertal children. Signiﬁcant associations were observed for changes in BMC ( )Pp .0348
and bone area ( ) in males but not females, independently supporting our observations of a mostly male-Pp .0286
speciﬁc effect, as seen in the adults. Together, these results suggest that LRP5 variants signiﬁcantly contribute to
LS–bone-mass and size determination in men by inﬂuencing vertebral bone growth during childhood.
Introduction
The lifetime risk of suffering an osteoporosis-related
fracture is 140% in women and 113% in men (Kanis
2002). This risk is largely inﬂuenced by the bone-mineral
density and size achieved in young adults (Duan et al.
2001a, 2001b). Twin and parent-offspring studies have
indicated that additive genetic effects account for 60%–
80% of the population variance in areal bone-mineral
density (aBMD), bone area, bone-mineral content (BMC),
and stature (Ferrari et al. 1998b; Eisman 1999). As with
other complex phenotypes, interindividual variation in
these traits seems to be determined at multiple loci (Per-
ola et al. 2001; Peacock et al. 2002). Many association
Received November 12, 2003; accepted for publication February
20, 2004; electronically published April 7, 2004.
Address for correspondence and reprints: Dr. Serge Ferrari, Division
of Bone Diseases, University Hospital of Geneva, 21, rue Micheli-du-
Crest, Geneva 1211, Switzerland. E-mail: serge.ferrari@medecine
.unige.ch
* These two authors contributed equally to this work.
 2004 by The American Society of Human Genetics. All rights reserved.
0002-9297/2004/7405-0009$15.00
studies with osteoporosis candidate genes have been per-
formed to date, but, so far, only small and often incon-
sistent differences in aBMD between genotypes have
been reported (Ferrari et al. 1999b; Peacock et al. 2002
[for review]). Therefore, allelic variants of genes with a
major contribution to bone mass and size remain to be
identiﬁed.
The low-density lipoprotein (LDL) receptor–related
protein 5 (LRP5) gene, which, in humans, maps to chro-
mosome 11q12-13, encodes a transmembrane protein of
1,615 amino acids that is a member of the LDL recep-
tor–related family (Hey et al. 1998). These proteins me-
diate WNT signaling through the b-catenin pathway
and are involved in Drosophila and mouse development
(Wodarz and Nusse 1998; Tamai et al. 2000).
Recently, several lines of evidence have pointed to the
LRP5 gene as a candidate susceptibility factor for os-
teoporosis in the general population. (1) Loss-of-func-
tion mutations in LRP5 are responsible for osteoporosis
pseudoglioma (OPPG [MIM 259770]), a rare autoso-
mal recessive disorder characterized by low bone mass,
spontaneous fractures, and blindness (Gong et al. 2001),
whereas LRP5 gain-of-function mutations cause high-
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bone-mass syndromes (HBM [MIM 601884]) (Boyden
et al. 2002; Little et al. 2002; Van Wesenbeeck et al.
2003). (2) Mice with targeted disruption of Lrp5 have
a deﬁcit in bone formation and sustain spontaneous
fractures (Kato et al. 2002). (3) AQTL for bone-mineral
density in the general population was mapped to 11q12-
13, the same chromosomal region where LRP5 is lo-
cated (Koller et al. 1998; Carn et al. 2002; Livshits et
al. 2002). Moreover, a QTL for stature has also been
identiﬁed in this region (Hirschhorn et al. 2001; Perola
et al. 2001), suggesting that the two traits may be in-
ﬂuenced by allelic variation of the same gene.
To investigate whether allelic variants of the LRP5
gene contribute to bone-mass and stature determination
in the general population (Patel and Karsenty 2002), we
ﬁrst studied the frequency and linkage disequilibrium
(LD) of 13 previously reported SNPs in a subset of our
sample. We then selected those polymorphisms that pro-
vided most of the genetic information to perform an
association study in our entire cohort, comprising
healthy adults, children, and adolescents of both sexes,
for which detailed bone-mass and size measurements at
the lumbar spine (LS) had been collected. To conﬁrm
and further dissect our results, we subsequently per-
formed a 1-year longitudinal association study in a sub-
group of 386 prepubertal children to assess the contri-
bution of LRP5 genotypes to vertebral bone growth.
Subjects and Methods
Cohort
For the association study, 889 healthy children, ado-
lescents, and adults of European descent were recruited
from among volunteers drawn from the population liv-
ing in Geneva, Switzerland. This cohort comprised 149
and 240 prepubertal girls and boys, respectively (Tan-
ner’s pubertal stage 1), of whom 148 girls and 238 boys
were re-evaluated after 1 year for the longitudinal study
(Bonjour et al. 1997, 2001); 74 female and 68 male
adolescents in Tanner’s pubertal stages 2–5 (Bonjour et
al. 1991; Theintz et al. 1992), of whom 15 female and
5 male adolescents had reached peak bone mass and
were thereafter classed as adults; 100 young men, stu-
dents at Geneva University (Ferrari et al. 1999a); and
186 pre- and perimenopausal women and 72 men who
were parents of some of the children and adolescents in-
cluded in the study cohort (Ferrari et al. 1998b, 1998c).
Most of these subjects have participated in a number of
previous studies of bone mass at our institution, and
their detailed inclusion/exclusion criteria have been re-
ported elsewhere (see references above).
Clinical Measurements
The aBMD (g/cm2), BMC (g), and projected bone area
(cm2) were measured at the LS (L2-L4 vertebrae) in an-
teroposterior view by dual X-ray absorptiometry (DXA)
withHologic QDR-1000, -2000, and -4500 instruments,
as reported elsewhere (see references above). The coef-
ﬁcient of variation at L2-L4was 1% for allmeasurements.
Stature was evaluated by measuring standing height
(without shoes) with a stapediometer (Holtain). Calcium
intake was evaluated using validated food-frequency
questionnaires completed under supervision of a trained
dietician (Bonjour et al. 1997; Ferrari et al. 1998c,1999a).
The study was approved by the ethics committee of the
University Hospitals of Geneva, and informed consent
for genotyping of osteoporosis candidate genes was ob-
tained from all participants and/or their parents.
SNP Genotyping
Genomic DNAwas extracted from blood lymphocytes
or mouth epithelial cells by use of the QIAmpDNAblood
kit (Qiagen). SNPswere genotyped by the pyrosequencing
method (Pyrosequencing), in which short regions includ-
ing the SNP are automatically sequenced through a series
of four enzymatic steps (Ronaghi 2001).We designed spe-
ciﬁc PCR primers for each SNP so that regions of ∼200
bp spanning the polymorphism were ampliﬁed (dbSNP
Database).
Data Analysis
Hardy-Weinberg equilibrium was tested for each SNP
by use of the HW Exact Test, as implemented in the
Genepop software (Garnier-Gere and Dillmann 1992).
To assign inferred haplotypes to each individual, we used
the HAPLOTYPER program and default parameters (Niu
et al. 2002). Haplotype frequencies were conﬁrmed by
the Arlequin program (Excofﬁer and Slatkin 1995). LD
for all SNP-pair combinations was calculated using the
DnaSP software (Rozas and Rozas 1995). For LD mea-
surement, we used the statistic. To determine whether2R
there was underlying population structure in our cohort
that could potentially generate false-positive associa-
tions, we ran the program STRUCTURE (Pritchard et
al. 2000), using genotype data of ﬁve markers located
in different genomic regions (LRP5, IL-6, VDR, LEPR,
and LEP).
For association analyses, stature, aBMD, BMC, and
projected bone area were adjusted for age and sex and
were expressed as standardized Z scores, by use of the
study population mean and SD for age and sex as ref-
erence (at 1-year intervals for children and at 5-year
intervals for adults). Z-score differences between LRP5
polymorphisms were tested by analysis of covariance
(ANOVA), with weight (Z scores) as a continuous vari-
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Figure 1 Schematic diagram of SNP localization in LRP5. Vertical bars represent the 23 exons of LRP5, and arrows indicate the positions
of the eight validated SNPs with a minimum allele frequency of 2%. SNPs encoding missense substitutions are boxed. Leading asterisks (*)
indicate SNPs used in the association study. Percentages indicate the frequency of the rare allele. The insert shows LD for all SNP pairs, calculated
as values. Gray-shaded coding represents the strength of LD ( values), according to the scale shown on the left. Leading asterisks (*)2 2R R
inside the boxes indicate the level of signiﬁcance for LD; one asterisk (*) denotes to .001, and two asterisks (**) denotes .Pp .01 P ! .001
able and with genotypes and sex as categorical variables.
Sex was included as a covariate to account for potential
interactions between sex and genotypes, since both ge-
nomewide screening in mice and association studies in
humans indicate that some genes may govern bone mass
in a sex-speciﬁc manner (Orwoll et al. 2001; Ferrari et
al. 2004). To avoid biases, only unrelated individuals
were analyzed at one time; that is, adults and children
were analyzed separately. To correct for multiple com-
parisons, we used a modiﬁed Bonferroni method, as de-
scribed by Sankoh et al. (1997), which takes into con-
sideration the level of correlation between linkedmarkers.
For the haplotype associations, the classical Bonferroni
correction was applied (hence P values .0125 were
considered signiﬁcant at ).ap 0.05
In prepubertal children, association of LRP5 poly-
morphisms with longitudinal changes in bone-massmea-
surements, calculated as the difference between values
obtained at baseline and after 1 year, were tested by two-
factor ANOVA, with genotypes and sex as independent
variables. Subsequently, differences between LRP5 ge-
notypes (and haplotypes) were tested by ANOVAwithin
sexes. The percentage of the population variance for each
trait explained by LRP5 genetic variation was estimated
as the R2 value from multiple regression analysis. This
included ﬁve LRP5 SNPs transformed into dummy vari-
ables (two homozygous for the rare allele, one hetero-
zygous, and zero homozygous for the common allele) as
independent and residuals of bone measurements—ad-
justed by age, sex, and weight—as dependent variables.
Results
Allele Frequencies and Haplotype Structure
We initially studied 13 SNPs, 10 of which were re-
ported elsewhere (Okubo et al. 2002; Van Wesenbeeck
et al. 2003) (table A [online only]), that were located in
the coding region or intron/exon junctions of the LRP5
gene. As a ﬁrst step, SNPs were genotyped for a sample
of 88 unrelated individuals randomly selected from
among 889 subjects in our cohort. Eight of the 13 SNPs
were found to have a minor-allele frequency of 2% in
our population (ﬁg. 1), and the genotype frequencies of
these 8 SNPs did not signiﬁcantly deviate from Hardy-
Weinberg equilibrium. On the basis of these polymor-
phisms, we inferred that 11 different haplotypes were
present in our study population, using a likelihood
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Table 1
Characteristics of Subjects in Cross-Sectional Study
CHARACTERISTIC
FINDINGS IN CHILDREN
AND ADOLESCENTS FINDINGS IN ADULTS
Male Female Male Female
No. of subjects 305 208 164 200
Agea (years) 9.13.0 9.93.0 34.412.9 40.28.0
Age range (years) 6.6–17.9 6.6–16.9 17.0–57.0 17.0–56.0
Heighta (cm) 135.017.7 137.715.9 178.06.5 164.06.3
Weighta (kg) 31.612.9 33.411.9 74.39.4 61.79.2
LS aBMDa (g/cm2) .629.144 .706.167 1.051.141 1.059.121
LS BMCa (g) 20.649.94 21.6311.13 56.2610.24 48.137.84
LS areaa (cm2) 31.616.48 29.117.22 53.284.42 45.293.94
a MeanSD.
method based on a Baysesian algorithm (Niu et al. 2002).
The most common haplotype had a frequency of 50%,
and four haplotypes accounted for 85% of the total
sample (table B [online only]). Signiﬁcant LD was ob-
served across the gene (ﬁg. 1), although LD was not
correlated with intermarker distance ( ;2R p 0.11 Pp
)..588
To reduce the number of tests for association, we dis-
carded SNPs with a minor-allele frequency !5% and
selected only one SNP for each pair of markers in nearly
complete LD ( ). Five SNPs, which we call the2R  0.9
“informative SNPs,” fulﬁlled these criteria; two of them
alter the amino acid sequence of the protein: missense
substitutions exon 9, c.2047GrA (p.V667M), and exon
18, c.4037CrT (p.A1330V) (ﬁg. 1).
To rule out potential population stratiﬁcation in our
study cohort, we ran the program STRUCTURE (Prit-
chard et al. 2000), using data from markers on ﬁve dif-
ferent independent loci that had been genotyped in 221
individuals from our sample (Ferrari et al. 1998a, 2003;
Quinton et al. 2001; Nieters et al. 2002). The highest
likelihood was obtained under the assumption of one
population ( ), and, for higher values of K, noneKp 1
of the individuals was assigned to a particular popula-
tion, thereby indicating that an unknown population
substructure was unlikely to be present in our cohort.
Cross-Sectional, Population-Based Association Study
in Adults
Among 889 subjects who were genotyped for these
ﬁve SNPs, 877 with complete data sets could eventually
be analyzed. To account for the age distribution of the
cohort, subjects were subdivided into “adults,” whom
we assumed had reached peak bone mass and size—that
is, the maximal amount of bone accumulated by the end
of the pubertal growth period (in this case, by the age
of 17.0 years for females and 18.0 years for males) (Riz-
zoli and Bonjour 1999)—and growing “children/adoles-
cents” (table 1). Association analyses were performed
using bone measurements and stature adjusted for age
and sex (Z scores) within these groups. Because of the
small number of genotype AA at c.1980 and c.2047 and
genotype TT at c.4037 ( , 4, and 13, respectively),np 3
these subjects were grouped with heterozygotes for each
speciﬁc SNP.
In adults, the most signiﬁcant and consistent associa-
tions with all LS bone measurements, as well as with
stature, occurred with the missense SNP in exon 9,
c.2047GrA (p.V667M) (table 2). After adjustment for
multiple comparisons, associations remained signiﬁcant
for LS BMC and area and for stature (P values .006
are signiﬁcant at after correction, given thatap 0.05
20 tests were performed with an average marker 2R p
). Associations with vertebral BMC and bone area0.3
were driven mainly by men, in whom average differences
between carriers and noncarriers of the exon 9 c.2047A
rare allele were 0.67 Z scores (ﬁg. 2). In contrast, dif-
ferences in stature between exon 9 c.2047GrA geno-
types were similar for both sexes (ﬁg. 2), corresponding
to an average 2.0 cm lower adult height in carriers of
the rare A allele. To our knowledge, this ﬁnding con-
stitutes the ﬁrst genetic variant to be linked to stature
in humans, although it explained !5% of the popula-
tion-based variance for the trait.
Although no signiﬁcant associations were observed
with the other four “informative SNPs” (table 2), single
SNPs may fail to capture all of the contribution of a
locus to a particular trait. We therefore tested associa-
tion, using inferred haplotypes assigned to each individu-
al. Reconstruction of haplotypes with the ﬁve informative
SNPs resulted in a number of haplotypes with low prob-
ability of correct assignment. Hence, we built haplotypes
using four informative SNPs (c.1980GrA, c.2047GrA,
c.3405ArG, and c.4037CrT), which yielded all haplo-
types with 1.98 probability of correct assignment (table
3).
The results of the haplotype association revealed sig-
niﬁcant Z-score differences in LS BMC and area among
870 Am. J. Hum. Genet. 74:866–875, 2004
Table 2
P Values for Association of LRP5 Polymorphisms with Vertebral Bone Mass and Stature in Adults
VARIABLE
P VALUE FOR GENOTYPEa
HAPLOTYPEbIVS4-4 TrC Exon 9 c.1980 GrA Exon 9 c.2047 GrA Exon 15 c.3405 ArG Exon 18 c.4037 CrT
aBMD .820 .087 .041 .551 .413 .062
BMC .716 .213 .003 .294 .182 .009
Area .531 .612 .001 .190 .092 .011
Stature .569 .852 .006 .733 .159 .447
NOTE.—P values for association with genotypes (and haplotypes) were calculated using ANCOVA, with weight and sex as independent
covariates and aBMD, BMC, bone area of the L2–L4 vertebrae, and stature standardized for age and sex (Z scores) as dependent variable.
Signiﬁcant P values, after correction for multiple comparisons, are in bold italics.
a Subjects homozygous for the rare alleles c.1980A, c.2047A, and c4037T were grouped with heterozygous carriers of the respective
genotypes.
b Haplotypes were built using the four exonic SNPs, as described in detail in table 3, and subjects were divided into 13 groups reﬂecting
all haplotype combinations that were present in the cohort.
adults of different haplotype groups, which remained
statistically signiﬁcant after correction for multiple com-
parisons (table 2; ﬁg. 3A). Stature, on the other hand,
showed no signiﬁcant differences with the haplotype
analysis, suggesting that only the c.2047 variant is likely
to play a role in the determination of this trait.
For all three LS bone parameters (aBMD, BMC, and
area) there was a marked trend for lower Z scores in
individuals carrying haplotype 4. Since haplotype 4 is
the sole haplotype that carries the c.2047A allele, which
was strongly associated with lower bone mass and size
when analyzed independently, this ﬁnding is consistent
with the genotype data. In addition, there was a trend
for higher Z scores in individuals with haplotype com-
binations 3,1; 3,2; and 3,3. However, since these groups
are scarcely populated ( subjects/group), and then  5
0,3 group ( ) hasZ scores close to zero, this analy-np 39
sis did not support a contribution of haplotype 3 to
vertebral bone mass and size phenotypes.
To reﬁne the haplotype analysis, we (1) performed a
sex-speciﬁc comparison, since the genotype data had
shown a mostly male-driven association, and (2) reduced
the number of classes by considering only SNPs at po-
sitions c.2047 and c.4037, the two missense polymor-
phisms, which are sufﬁcient to deﬁne themost interesting
haplotypes. This resulted in only three haplotypes: hap-
lotype 0′—which combines haplotypes 0, 1, and 2
(c.2047G-c.4037C)—and haplotypes 3 and 4, which are
the same as those deﬁned in table 3.
The results of this analysis (ﬁg. 3B) conﬁrm a strong
sex-speciﬁc effect (as with the genotype data), since,
whereas in the women, there are no signiﬁcant differ-
ences between the haplotypic groups, in men, signiﬁcant
differences are present (0.8 Z scores), mainly driven
by haplotype 4. The increased Z scores observed for
individuals carrying haplotype 3 suggest that this hap-
lotype could also contribute to the vertebral bone traits
in men and deserves further investigation.
Altogether, LRP5 polymorphisms accounted for 4.0%
and 3.8% of the adult population variance in LS BMC
and area (independent of age and weight), respectively.
It is remarkable that, in men, the contribution of LRP5
alleles reached 15.4% and 12.7% for BMC and area,
respectively.
Cross-Sectional and Longitudinal Association Study
in Childhood
Similar association studies with genotypes and hap-
lotypes were performed independently in the children
and adolescent group of our cohort, but only marginal
associations with aBMD and BMC were observed for
the exon 9 c.2047 SNP (data not shown), and no as-
sociations were observed with the haplotypes (table C
[online only]).
These observations led us to hypothesize that LRP5
variants might inﬂuence vertebral bone size andmass gain
during growth, in which case, association of LRP5 al-
leles with the cross-sectional bone measurements would
not be fully expressed in children. To test this hypothesis,
we studied the association of LRP5 variants with lon-
gitudinal changes in LS parameters in 386 children from
the original cohort whowere remeasured after 1 year (148
girls and 238 boys). Since the polymorphism at position
c.2047 and the two-SNP haplotypes (c.2047 and c.4037)
were the most informative in the adults, we focused on
those markers for the longitudinal analysis. As shown
in ﬁgure 4A, the GA/AA genotypes were indeed asso-
ciated with smaller gain in bone area in the boys. This
was not observed in the growing girls (see below), con-
sistent with the adult data, in which most of the asso-
ciation with vertebral Z scores was driven by men (ﬁg.
2).
We then looked at haplotype association with changes
in vertebral bone mass and size, using the reduced num-
ber of haplotypes already deﬁned in the adults, namely
0′, 3, and 4. Age, weight, and calcium intake at baseline
and during follow-up, all factors known to inﬂuence
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Figure 2 Differences in adult LS bonemeasurements and stature,
according to LRP5 exon 9 missense SNP and sex. Stature and aBMD,
BMC, and bone area at the LS were measured cross-sectionally in 364
adult subjects of both sexes. Results are mean Z scores  SEM ad-
justed for age and sex. Only signiﬁcant P values (measured by
ANCOVA), with weight as covariate, within sexes are shown.
Table 3
Haplotypes of “Informative SNPs” in the Cross-
Sectional Cohort
SNP
NUCLEOTIDES FOR HAPLOTYPE
( )np 889
0a 1b 2c 3d 4e
Exon 9 c.1980 GrA G A G G G
Exon 9 c.2047 GrA G G G G A
Exon 15 c.3405 ArG A G G G G
Exon 18 c.4037CrT C C C T T
a Frequency (%) p 65.8.
b Frequency (%) p 6.52.
c Frequency (%) p 11.7.
d Frequency (%) p 8.44.
e Frequency (%) p 7.4.
bone-mass gain in childhood, were similar among hap-
lotypic groups (table C [online only]).
Signiﬁcant differences between the haplotype groups
were observed only in the growing boys (ﬁg. 4B), with
carriers of haplotype 4 having lower BMC and area gains,
particularly when compared with carriers of haplotype
3, who showed a slight trend for higher gains. The pat-
tern in the growing boys resembled that of the adults (ﬁg.
3B), suggesting a consistent sex-related effect of LRP5 to
LS bone-mass and size acquisition.
In the girls, a nonsigniﬁcant trend for higher gains was
observed for carriers of the c.2047A variant and hap-
lotype 4, opposite to what was seen in the boys. But
since this effect was not present in the adults, the biologi-
cal relevance of this observation is uncertain.
Discussion
We performed a cross-sectional association study to an-
alyze the contribution of LRP5 polymorphisms to varia-
tion in LS bone mass and size in a large sample of white
Europeans. To this end, we studied the LD structure of
the gene and selected ﬁve SNPs that provide most of the
genetic information for this locus, which we genotyped
in 364 healthy adults and 513 children and adolescents.
We identiﬁed a missense substitution in exon 9 of the
gene (c.2047GrA) that, in adults, is signiﬁcantly asso-
ciated with LS bone mass (BMC), projected bone area,
and stature and is marginally associated with LS aBMD.
Our ﬁndings are therefore consistent with previous re-
ports of QTLs for bone-mineral density and stature in
humans, both mapping to 11q12-13 (Koller et al. 1998;
Hirschhorn et al. 2001; Perola et al. 2001; Carn et al.
2002; Livshits et al. 2002), the genomic region where
LRP5 is located. Together with variants in the vitamin
D–receptor gene (van der Sluis et al. 2003),LRP5 genetic
variation is one of the ﬁrst identiﬁed common genetic
determinants of vertebral bone size and stature inwhites.
To better describe the contribution of the locus to the
determination of LS bone phenotypes, we studied the
LRP5 genetic variants in the context of their haplotypes.
Recent publications involving large cohorts, multiple
SNPs, and haplotype analysis, such as for TNFRSF1B
and ESR1 (Albagha et al. 2002; van Meurs et al. 2003),
have indeed shown robust associations between hap-
lotypes and bone phenotypes.
The haplotype associations revealed large differences
in bone parameters between the different groups, which
were as much as 2 SDs in some cases (ﬁg. 3A). The main
genetic determinant behind the genotype and haplotype
associations was the c.2047GrA variant that deﬁnes
haplotype 4. Nevertheless, the increase in Z scores ob-
served for carriers of haplotype 3 in the males (ﬁg. 3B)
suggests that additional polymorphic sequences within
this locus might contribute to the vertebral bone traits.
The associations observed in the adult group were
clearly driven by the men, as seen in ﬁgures 2 and 3B,
suggesting that some sex-speciﬁc factors, such as go-
nadal steroids (which are known to play a major role
in bone homeostasis [Rizzoli and Bonjour 1997; Khosla
et al. 2001]) or sequences in the X or Y chromosomes,
directly or indirectly affect the action of LRP5 on bone
phenotypes. Similar ﬁndings have recently been reported
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Figure 3 Differences in adult LS measurements, according to LRP5 haplotypes. aBMD, BMC, and bone area at the LS were measured
cross-sectionally in men and women and were expressed as standardized Z scores (SE). Haplotypes were based on SNPs c.1980, c.2047,
c.3405, and c.4037, as detailed in table 3. Sizes for haplotype groups in adults of both sexes (panel A) are as follows: 0,0 ; 0,1np 156 np
; 0,2 ; 0,3 ; 2,1 ; 2,2 ; 3,1 ; 3,2 ; 3,3 ; 4,0 ; 4,1 ; 4,2 ; 4,3 . Group21 np 50 np 39 np 4 np 5 np 2 np 5 np 2 np 44 np 5 np 7 np 4
sizes for the reduced haplotype combinations in female/male (females indicated by blackened circles; males indicated by unblackened squares)
(panel B) are as follows: 0′,0′ (0′p2047G-4037C), ; 0′,3 (3p2047G-4037T), ; 0′,4 (4p2047A-4037T), . Pnp 133/112 np 29/19 np 31/27
values for overall differences between haplotype groups were calculated by use of ANCOVA, with weight as a covariate.
for haplotypes in the ESR1 gene, which were found to
be associated with vertebral bone area and fracture risk
in females but not in males (van Meurs et al. 2003).
These data support the notion that loci conferring risk
for spine osteoporosis frequently do so in a sex-speciﬁc
manner.
To conﬁrm and further dissect the associations ob-
served in the adults, we performed similar cross-sec-
tional studies in the children, but no signiﬁcant differ-
ences were observed at that stage of development. This
might be explained by the fact that LRP5 gene variants
inﬂuence the bone phenotypes during growth; hence,
children have not had time to express these differences.
To directly test this hypothesis, we performed a 1-year
longitudinal study of 386 children from the original
cohort.
We observed signiﬁcant differences in bone-mass and
size gain in growing boys that were consistent with the
pattern of Z-score distribution observed in the men, in
that boys carrying haplotype 4 had signiﬁcantly smaller
gains when compared with the other groups, in particu-
lar with those individuals carrying haplotype 3 (ﬁg. 4B).
As with the adults, the signiﬁcant P value was mainly
driven by haplotype 4; however, the fact that haplotype
3 carriers also showed a mild effect is interesting. In
contrast, growing girls carrying haplotype 4 appeared
to have a marginally higher bone-mass acquisition com-
pared with the other groups. Since these differences did
not translate into signiﬁcant Z-score differences in
women, they are unlikely to be biologically relevant.
It is also interesting to compare haplotype-speciﬁc
gain in bone mass across sexes, since, although the over-
all amount of gain (for both phenotypes) is roughly the
same in both sexes, its distribution among haplotype
groups is very different. Thus, there would seem to be
clear interactions between haplotypes 3 and 4 and sex
(P interaction p .0008 for BMC and .026 for area).
Overall, the results of the longitudinal study indepen-
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Figure 4 Changes in LS bone size and mass during childhood,
according to LRP5 exon 9 c.2047 genotypes and haplotypes. Mean
changes (SEM) in LS BMC and projected area were evaluated be-
tween baseline and 1 year in prepubertal males (M) and females (F).
Panel A shows mean changes according to c.2047 genotypes, panel B
according to reduced haplotype combinations, as in ﬁgure 3B. The
number of females/males in each group is as follows: 0′,0′, np
; 0′,3, ; 0′,4, . Signiﬁcant P values for109/168 np 22/38 np 16/29
differences between exon 9 genotypes and between haplotypes 3 and
4 are shown.
dently conﬁrmed the association of haplotype 4 to lower
Z scores (for BMC and area) in the men and suggest that
the main effect of LRP5 on bone-phenotype variation is
during growth, when it affects bone mass at the spine,
mainly through the determination of vertebral-bone size
(Seeman 2002).
An important aspect of our study that deserves fur-
ther investigation concerns the functional role of the
c.2407GrA SNP that was found to be associated with
LS bone traits. Although it results in an amino acid
substitution (p.V667M), it is not clear whether and how
it affects the function or expression of the LRP5 protein.
The localization of the p.V667M substitution at the top
of the third propeller module in the receptor extracel-
lular domain, similar to most missense mutations caus-
ing the OPPG and HBM syndromes, is intriguing (Gong
et al. 2001; Boyden et al. 2002; Little et al. 2002).
However, in vitro assays to functionally test the con-
sequences of this polymorphism are necessary to under-
stand whether this SNP is causative or is in LDwith some
other genetic variation, outside the coding sequence, that
might have a regulatory effect (Twells et al. 2003). In
addition, further characterization of haplotype 3, either
by functional tests or by additional population- or fami-
ly-based studies, should help clarify that haplotype’s po-
tential functional involvement.
In summary, our ﬁndings indicate that LRP5 allelic
variation contributes signiﬁcantly to the determination
of vertebral bone mass and size, mostly in white males.
Taken together with the accumulating strong evidence
of a major role of LRP5 in bone metabolism, LRP5
variants appear as potentially important genetic sus-
ceptibility factors for osteoporosis and vertebral frac-
tures, particularly in men.
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